ORIGINAL RESEARCH article

Front. Pharmacol., 03 June 2024

Sec. Experimental Pharmacology and Drug Discovery

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1405446

The impact of abstinence from chronic alcohol consumption on the mouse striatal proteome: sex and subregion-specific differences

  • 1. Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States

  • 2. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, United States

  • 3. Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States

Abstract

Alcohol misuse is the third leading preventable cause of death in the world. The World Health Organization currently estimates that 1 in 20 deaths are directly alcohol related. One of the ways in which consuming excessive levels of alcohol can both directly and indirectly affect human mortality and morbidity, is through chronic inflammation. Recently, studies have suggested a link between increased alcohol use and the incidence of neuroinflammatory-related diseases. However, the mechanism in which alcohol potentially influences neuroinflammatory processes is still being uncovered. We implemented an unbiased proteomics exploration of alcohol-induced changes in the striatum, with a specific emphasis on proteins related to inflammation. The striatum is a brain region that is critically involved with the progression of alcohol use disorder. Using mass spectrometry following voluntary alcohol self-administration in mice, we show that distinct protein abundances and signaling pathways in different subregions of the striatum are disrupted by chronic exposure to alcohol compared to water drinking control mice. Further, in mice that were allowed to experience abstinence from alcohol compared to mice that were non-abstinent, the overall proteome and signaling pathways showed additional differences, suggesting that the responses evoked by chronic alcohol exposure are dependent on alcohol use history. To our surprise we did not find that chronic alcohol drinking or abstinence altered protein abundance or pathways associated with inflammation, but rather affected proteins and pathways associated with neurodegeneration and metabolic, cellular organization, protein translation, and molecular transport processes. These outcomes suggest that in this drinking model, alcohol-induced neuroinflammation in the striatum is not a primary outcome controlling altered neurobehavioral function, but these changes are rather mediated by altered striatal neuronal structure and cellular health.

Introduction

Alcohol Use Disorder (AUD) is a rising public health crisis that affects over 29.5 million people ages 12 and older (SAMHSA, 2021; NIAAA, 2024). AUD is characterized by a pattern of alcohol consumption that is associated with symptoms such as increased alcohol craving and consumption, and the inability to stop drinking. This disorder is associated with several neurological effects including cognitive impairment, memory loss, and anxiety (Wilcox et al., 2014; Bloch et al., 2020; Spinola et al., 2022). Its development is complex and involves a combination of genetic, environmental, and psychological factors (McLellan et al., 2000). Currently, there are three drugs approved by the US Food and Drug Administration (FDA) to treat individuals who suffer from AUD: Disulfiram (inhibitor of aldehyde dehydrogenase to increase acetaldehyde), Naltrexone (inhibitor of opioid receptor to reduce drug-related euphoria), and Acamprosate (inhibitor of NMDA glutamate receptor) (Alcoholism, 2024). However, many individuals fail to successfully abstain after treatment, and usually relapse within a year (Maisto et al., 2003). As such, AUD treatment remains a challenge as a critical gap exists concerning the neural regulation of alcohol consumption and relapse to alcohol misuse.

Chronic alcohol consumption impairs cognition, decision-making, attention, and learning by disrupting the structure and function of various brain regions (Evert and Oscar-Berman, 1995; Topiwala et al., 2017). The striatum is one such region that is significantly involved in the reinforcement of alcohol use due its role in the addiction cycle (Koob and Le Moal, 1997; Koob and Volkow, 2010). This region’s structures and functions are classically involved in the binge/intoxication stage of the addiction cycle (Substance Abuse and Mental Health Services Administration, 2016). The nucleus accumbens (NAc), also known as the ventral striatum, is heavily involved in the initial stages of drug reward and reinforcement (Gremel and Costa, 2013). The dorsal striatum (DS) also plays a major role in action selection behaviors, such as drug seeking and habit formation. The dorsomedial striatum (DMS) and dorsolateral striatum (DLS) are subregions of the DS that mediate different forms of action selection. The DMS governs goal-directed actions while the DLS governs habitual behaviors (Balleine and O'Doherty, 2010; Corbit et al., 2012; Valentin et al., 2007). As alcohol drinking behavior progresses and becomes habitual, control can shift from the NAc and DMS to the DLS (Willuhn et al., 2012; Bell et al., 2016). Studies show that striatal regions undergo modifications to synapses in response to alcohol use including receptor changes and altered connectivity between brain regions (Sulzer, 2011; Flores-Bastias and Karahanian, 2018; Lieselot et al., 2023). While prior research has uncovered much about how neural firing across the striatum correlates with alcohol drinking, the molecular mechanisms that are altered by chronic alcohol consumption remain unclear.

One way that alcohol consumption may impact brain function is by driving pro-neuroinflammatory states (He and Crews, 2008). Chronic alcohol drinking induces neuroinflammatory responses such as microglia recruitment, proliferation and activation which results in increases in pro-inflammatory markers such as cytokines and Toll-like receptor 4 (TLR4) activation (Zou and Crews, 2005; Fernandez-Lizarbe et al., 2013; Crews and Vetreno, 2016; Marshall et al., 2016; Siemsen et al., 2021; Swartzwelder et al., 2019; Crews et al., 2023). Supporting a potential causative role for inflammation in alcohol consumption, anti-inflammatory drugs can affect alcohol drinking behavior (Blaker and Yamamoto, 2018; Macht et al., 2021; Kline and Yamamoto, 2022). Previous work from our laboratory has demonstrated that inhibition of the prostaglandin E2 (PGE2) receptor as well as cyclooxygenase-2 (COX-2) reduce alcohol reinstatement in adolescent female rats after a period of abstinence from alcohol drinking (Kline and Yamamoto, 2022). A potential molecular mechanism that underlies these effects is that alcohol drinking increased expression of the pro-inflammatory mediators, endothelin-1 (ET-1), COX-2, and PGE2 during alcohol abstinence which may account for the ability of the anti-inflammatory treatments to reduce reinstatement of drinking (Kline and Yamamoto, 2022). Of particular interest, these molecular changes were only observed in the DS, but not the NAc, suggesting that elevated inflammation locally in the DS may drive reinstatement of alcohol drinking after abstinence.

To follow up on this work, we performed an unbiased proteomic assessment of the effects of alcohol drinking on dorsal and ventral striatum protein expression. Our goal was to identify all potential inflammatory mediators that may contribute to alcohol drinking and alcohol reinstatement following a period of abstinence. To do so, we used a model of chronic alcohol consumption with acute and protracted alcohol abstinence in adult male and female mice followed by proteomics measures. We hypothesized that there would be differences in the abundance of proteins that are an expanded part of the same signaling pathways as was seen in our rat model.

Methods

Animals

All animal research was done according to approved protocols by the Indiana University School of Medicine Institutional Animal Care and Use Committee (IACUC) and with guidelines established by the National Institutes of Health (NIH). 48 seven-week-old mice (24 males and 24 females) were obtained from Jackson Laboratories (Bar Harbor, ME) and single housed in a reversed light cycle room (12h light/dark cycle). Mice were allowed to acclimatize for 1 week before commencing drinking.

Voluntary intermittent access two-bottle choice drinking

All water and ethanol drinking were done using home cage lickometers that were constructed in-house as described in previous work done in our lab (Haggerty et al., 2022). The lickometers hold two tubes simultaneously, with one on each side. Control animals had access to two tubes of water while alcohol drinkers had access to one water tube and an alcohol tube during each drinking session. Alcohol and water tubes were weighed and placed in cages on Mondays, Wednesdays and Fridays of each week, 3 h after the light cycle ended (09:00 h). Each session lasted 24 h. At the end of each session, the bottles were immediately weighed, and water bottles were placed in the cages until the next session. Animals were given an increasing concentration of alcohol (3%, 6% and 10% v/v in water) for two sessions each, and then given a concentration of 20% for the remaining drinking sessions. Animals drank for a total of 15 sessions. Mice were weighed at the end of the final drinking session each week. Alcohol and water consumption was calculated in grams per kilograms (g/kg) by using the weight difference of the bottles and the density of alcohol and water, respectively. Alcohol preference percentage was calculated by dividing the total volume of alcohol consumed by the volume of total fluid (water plus alcohol) and multiplying by 100. One group of animals underwent 3 weeks of abstinence from alcohol drinking (protracted abstinence) and a second group underwent 24 h of abstinence from alcohol drinking (acute abstinence). Animals were given ad libitum access to food. Supplementary Figure S1 displays the experimental design and timeline. Supplementary Figure S1 was made using BioRender software with a license to publish it.

Proteomics

All proteomics experiments were performed in collaboration with the Indiana University Proteomics Core similarly to previous work done in our lab (Grecco et al., 2021; Grecco et al., 2022; Haggerty et al., 2023).

Tissue dissection

Tissue collection was done 24 h after the final drinking session for the acute abstinence cohort and 3 weeks after the final session for the protracted abstinence cohort. One female water drinker in the protracted abstinence group was excluded from tissue collection due to a homecage malfunction which resulted in the animal leaving the cage during the drinking session. Animals were rapidly decapitated after a brief exposure to anesthesia and tissue was dissected. Slices were cut in a 0.5 mm coronal mouse brain matrix, and DLS, DMS and NAc sections were dissected from each slice. Tissue was immediately snap frozen in isopentane on dry ice and stored at −80 until later processing.

Protein preparation

We prepared proteins in the same way as our previous works (Grecco et al., 2021; Grecco et al., 2022; Haggerty et al., 2023): Flash frozen brain sections were homogenized in 150–170 µL of 8 M urea in 100 mM Tris, pH 8.5 using a Bioruptor® sonication system (Diagenode Inc. United States, North America Cat No: B01020001) with 30 s/30 s on/off cycles for 20 min in a water bath at 4°C. After subsequent centrifugation at 10,000 rcf for 20 min, protein concentrations were determined by Bradford protein assay (BioRad Cat No: 5000006). Approximately 25 µg of protein from each sample were then treated with 5 mM tris(2-carboxyethyl) phosphine hydrochloride (Sigma-Aldrich Cat No: C4706) to reduce disulfide bonds and the resulting free cysteine thiols were alkylated with 10 mM chloroacetamide (Sigma Aldrich Cat No: C0267). Samples were diluted with 50 mM Tris.HCl pH 8.5 (Sigma-Aldrich Cat No: 10812846001) to a final urea concentration of 2 M for overnight Trypsin/Lys-C digestion at 35°C (1:25 protease:substrate ratio, Mass Spectrometry grade, Promega Corporation, Cat No: V5072.) (Levasseur et al., 2019; Li et al., 2020).

Peptide purification and labeling

Digestion was halted by addition of 0.3% v/v trifluoroacetic acid (Millipore Cat No: 152166), and peptides were desalted on Waters Sep-Pak® Vac cartridges (WatersTM Cat No: WAT054955) with a wash of 1 mL 0.1% TFA followed by elution in 0.6 mL of 70% acetonitrile 0.1% formic acid (FA). Peptides were dried by speed vacuum and resuspended 50 mM triethylammonium bicarbonate (TEAB; Sigma Cat No: 102614922). Each sample was labeled for 2 h at room temperature with 0.5 mg of Tandem Mass Tag Pro (TMTpro) reagent resuspended in acetonitrile (16-plex kit, manufactures instructions Thermo Fisher Scientific, TMTpro™ Isobaric Label Reagent Set; Cat No: 44520, Lot no. XK347989) (Li et al., 2020). Samples were checked for >90% labeling efficiency prior to being quenched with 0.3% hydroxylamine (v/v) at room temperature for 15 min. Labeled peptides were then mixed and dried by speed vacuum.

Internal reference channel

Since the maximum number of samples that can be multiplexed using TMTpro is currently 18, in order to compare samples across multiple multiplexes, an internal reference channel was created for each brain region by pooling an equivalent amount of digested peptide from each sample after resuspension in TEAB, but prior to TMTpro labeling (Plubell et al., 2017). This pooled sample was labeled with TMTpro 134C, and divided equally to be mixed with each individual multiplex prior to high pH fractionation.

Trigger channel creation

Since data dependent mass spectrometry can be stochastic in which specific peptides are selected for isolation, fragmentation and thus quantification, we created a trigger channel (Peck Justice et al., 2021) containing peptides from a selection of inflammatory proteins of interest identified by Western blot in our prior work (Blaker and Yamamoto, 2018). We selected peptides from previous mass spectrometry analysis (Grecco et al., 2021; Grecco et al., 2022; Haggerty et al., 2023), and when not previously identified by mass spectrometry, from high scoring peptides on peptideatlas.org (Desiere et al., 2006). Peptides were purchased from Biosynth, and a 100 µg of an equimolar solution of 8 peptides were labeled with TMTPro channel 135N. 1 ug of this labeled peptide mixture was added to each multiplex prior to high pH fractionation. Supplementary Table S1 shows the proteins and peptides represented in the trigger channel.

High pH basic fractionation

For high pH basic fractionation, the combined, dried peptides for each multiplex were reconstituted in 0.1% FA and fractionated into 8 fractions using Pierce™ High pH reversed-phase peptide fractionation kit (Thermo Fisher Scientific Cat No 84868).

Nano-LC-MS/MS analysis

Nano-LC-MS/MS analysis was performed as described previously (Grecco et al., 2021; Grecco et al., 2022; Haggerty et al., 2023) on an EASY-nLC™ HPLC system (SCR: 014993, Thermo Fisher Scientific) coupled to Orbitrap Fusion™ Eclipse™ mass spectrometer (Thermo Fisher Scientific). One fourth of each global peptide fraction was loaded onto a reversed phase 25 cm aurora column (IonOpticks, AUR2-25075C18A) at 400 nL/min in the EASY-nLC HPLC system (SCR: 014993, Thermo Fisher Scientific). The gradient used for the separation is 5%–30% with mobile phase B for 160 min, 30%–80% B over 10 min, and 80%–10% B in last 10 min [Mobile phases A: 0.1% FA, water; B: 0.1% FA, 80% Acetonitrile (Thermo Fisher Scientific Cat No: LS122500)]. Nano-LC-MS/MS data were acquired in Orbitrap Eclipse™ Tribid mass spectrometer (Thermo Fisher Scientific) installed with a FAIMS pro interface. The mass spectrometer was operated in positive ion mode with advanced peak determination and Easy IC™ on and with 3 FAIMS CVs (−45, −55, −70), 1.3 s cycle time per CV. Precursor scans (m/z 400–1600) were done with an orbitrap resolution of 120,000, RF lens% 30, maximum inject time 105 ms, standard AGC target, MS2 intensity threshold of 2.5e4, including charges of 2–6 for fragmentation with 60 s dynamic exclusion. MS2 scans were performed with a quadrupole isolation window of 0.7 m/z, 34% HCD CE, 50,000 resolution, 200% normalized AGC target, dynamic maximum IT, fixed first mass of 100 m/z. The data were recorded using Thermo Fisher Scientific Xcalibur (4.3) software (Thermo Fisher Scientific Inc.).

Proteome data processing

We analyzed our proteomics data as we have done before (Grecco et al., 2021; Grecco et al., 2022; Haggerty et al., 2023): resulting RAW files were analyzed in Proteome Discover™ 2.5 (Thermo Fisher Scientific, RRID: SCR_014477) with a Mus musculus UniProt FASTA Reference proteome downloaded 022823 plus common contaminants. SEQUEST HT searches were conducted with a maximum number of 3 missed cleavages; precursor mass tolerance of 10 ppm; and a fragment mass tolerance of 0.02 Da. Protein FDR validator node was set to a strict target FDR of 0.01 and relaxed of 0.05. Resulting normalized abundance values for each biological sample, abundance ratio and log2 (abundance ratio) values; and respective p-values (protein abundance-based ratio calculation and ANOVA test) from Proteome Discover™ were exported to Microsoft Excel. Static modifications used for the search were 1) carbamidomethylation on cysteine (C) residues; 2) TMTpro label on lysine (K) residues. Dynamic modifications used for the search were TMTpro label on N-termini of peptides, oxidation of methionines, phosphorylation on serine, threonine or tyrosine, and acetylation, methionine loss or acetylation with methionine loss on protein N-termini. Percolator False Discovery Rate was set to a strict setting of 0.01 and a relaxed setting of 0.05. IMP-ptm-RS node was used for all modification site localization scores. Values from both unique and razor peptides were used for quantification. In the consensus workflows, peptides were normalized by total peptide amount with no scaling. Quantification methods utilized TMTpro isotopic impurity levels available from Thermo Fisher Scientific. Reporter ion quantification was allowed with S/N threshold of 7 and co-isolation threshold of 50%. Individual multiplex comparisons were analyzed using Proteome Discover™ were exports directly while comparison of multiple multiplexes was done after exporting PSM level intensity data to Excel.

Gene ontology and biological pathways enrichment analysis

All protein abundance is displayed as the log2 abundance ratios of alcohol/water. Proteins that that had abundances with a p-value of less than 0.05 were normalized across animals by their UniProt Accession numbers and displayed using dendrograms. Proteins were clustered according to their distinct interactions. The related Gene IDs were loaded into g:Profiler (https://biit.cs.ut.ee/gprofiler) to determine protein-protein interaction and their associated networks. A Benjamini-Hochberg FDR significant threshold was selected and a user threshold of 0.01. Gene Ontology (GO) data was filtered for GO Biological Process. This data was then inserted into Revigo (http://revigo.irb.hr) (Supek et al., 2011), an online tool that summarizes extensive lists of GO terms by clustering like terms under main categories. The resulting list was set to medium (0.5), the associated values used were the adjusted p-values, and the species was set to Mus musculus. Biological pathways were assessed using the KEGG database. The resulting data were analyzed for proteins and pathways in the DLS, DMS and NAc that were common to the acute and protracted abstinence groups. This was done using the Venn diagram creator function in Bioinformatics and Revolutionary Genomics (https://bioinformatics.psb.ugent.be/webtools/Venn/). The full results from the GO analyses are available at: https://github.com/bduffus/Chronic-Alcohol-Abstinence-Proteome.

Statistics and data visualization

Data are expressed as scatterplots and line graphs. The lines of drinking data graphs represent the mean while the shaded regions represent standard deviation. Box plots show the data extending from the 25th to 75th percentiles with whisker characterizing minimum and maximum values and diamonds identifying outlying data points. Heatmaps show a subgroup of significantly regulated proteins in males and females of each abstinence group. Seaborn and matplotlib python libraries were used to construct graphs, box plots and heatmaps. Statistical analyses were performed using GraphPad Prism (GraphPad Software V10.1.1) and pingouin. All analyses are based on an a priori cut-off α value for significance of p < 0.05. A two-way mixed analyses of variances (ANOVA) was used (for data with missing values due to leaks in drinking tubes) to analyze the drinking data from the voluntary two-bottle choice intermittent access drinking, with sex, and treatment (fluid) as the factors. Proteomics analyses were done by normalizing the alcohol/water abundance ratio to the group mean within each drinking group by sex.

Results

Females drank more water and alcohol over time for both the acute and protracted abstinence groups

Mice underwent two-bottle choice voluntary drinking and were then divided into two groups: an acute abstinence and a protracted abstinence group. The acute abstinence group went through 24 h of alcohol abstinence following the last drinking session while the protracted abstinence group went through 3 weeks of abstinence from alcohol. Both groups are shown together in Figure 1 to display drinking patterns, and then analyzed separately for all other experiments. To ensure only true drinking values were analyzed, sessions with malfunctions like bottle leaks were excluded from analysis. As alcohol concentration increased over time, so did the amount of alcohol consumed in individual mice who were exposed to alcohol (Figure 1A). Total water consumption remained mostly steady throughout the 15 drinking sessions, however, a time effect was seen at sessions 11, 13, 14 and 15 (Figure 1B). When analyzed by sex, females exhibited a greater amount of alcohol consumption than males over time (Figures 1C, D). There was an effect of time on both males and females and an interaction of sex and time was also found. Water consumption also differed in females and males, with females showing an overall higher intake (Figures 1E, F). For the first 6 sessions, the alcohol concentration was increased from 3% to 6%–10%, with mice getting access to each concentration for 2 drinking sessions. The concentration was then increased to 20% for the remaining sessions. Overall, there was no difference in the preference for alcohol over water between males and females (Figure 1G). However, the concentration of alcohol had an effect on preference.

FIGURE 1

Acute abstinence from alcohol produced more proteome changes than protracted abstinence

To determine distinct modifications in mouse brain regions due to alcohol abstinence, we dissected the striatum into three brain regions: DMS, DLS and NAc. We then performed mass spectrometry and analyzed proteins that were differentially expressed as a product of alcohol drinking with different lengths of post-drinking abstinence. Protein analyses were done within each brain region, sex, and abstinence group.

In the DLS of female mice that went through acute abstinence, a total of 570 proteins’ abundances were significantly altered, with 311 increased and 259 decreased proteins (Figure 2A). In males, fewer proteins were significantly differentially abundant; 42 proteins were increased and 36 proteins were decreased (Figure 2B). Clusterplots with dendrograms show significantly abundant proteins in the DLS of acute abstinence males (Figure 2C) and females (Figure 2D) based on their similarity. Proteins in alcohol and water drinkers were seen to be most dissimilar in females, however there was no clear distinction of proteins in males.

FIGURE 2

The opposite trend was seen in the protein abundances for males and females that underwent protracted abstinence, as males showed a larger number of proteins with significantly altered abundance. Females had 20 increased and 61 decreased proteins (Figure 2E) while males had 268 increased and 342 decreased proteins (Figure 2F). The clusterplots also displayed an opposing trend to the acute group, where protein abundances for male alcohol and water drinkers were most dissimilar but there was not a consistent pattern for females (Figures 2G, H). The top 10 increased and decreased proteins in the DLS in each sex and abstinence group are listed in Table 1.

TABLE 1

Accession #Descriptionp-valueAccession #Descriptionp-value
Top 10 Upregulated in acute femaleTop 10 Upregulated in acute male
A0JP43EF-hand calcium-binding domain-containing protein 54.43E-07A0A1D5RML8DNA-directed RNA polymerase II subunit RPB30.0469
Q9EST4Proteasome assembly chaperone 21.82E-06Q66L47Guanine nucleotide binding protein, alpha stimulating, olfactory type0.0142
Q9CWT6Probable ATP-dependent RNA helicase DDX281.31E-07P28867Protein kinase C delta type0.0010
E9PUQ3NKAP domain-containing 14.49E-05Q9WTW5Solute carrier family 22 member 30.0465
A0A0U1RP06DNA repair protein-complementing XP-C cells homolog (Fragment)1.12E-05H3BLI8WD repeat domain 170.0007
V9GXG1Protein SLFN142.54E-05Q80YS4receptor protein-tyrosine kinase0.0481
E9Q099Oviduct-specific glycoprotein1.12E-06Q5DU31Interactor protein for cytohesin exchange factors 10.0306
Q8BTK5SET and MYND domain-containing protein 48.09E-07Q9WV27Sodium/potassium-transporting ATPase subunit alpha-40.0264
Q5FW96Nuclear receptor subfamily 1 group I member 38.06E-07C3S7Q5Ojoplano variant A0.0325
Q9ER47Potassium voltage-gated channel subfamily H member 72.28E-07E9QNX9Tyrosine-protein kinase receptor0.0437
Top 10 downregulated in acute femaleTop 10 downregulated in acute male
Q68FM4protein-tyrosine-phosphatase1.00E-05Q91VJ5Polyglutamine-binding protein 10.0341
V9GWU7non-specific serine/threonine protein kinase9.07E-08Q8BN72ATP-dependent RNA helicase DHX290.0223
F8WHT3Protein PRRC2B1.25E-02O54983Ketimine reductase mu-crystallin0.0108
Q8BM75AT-rich interactive domain-containing protein 5B3.29E-04F8VQ875′-3′ exoribonuclease 10.0440
B1AWL5Zinc finger protein 4628.11E-05Q80UF4Serologically defined colon cancer antigen 8 homolog0.0353
P97427Dihydropyrimidinase-related protein 11.50E-06Q9Z0H3SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 10.0371
P03893NADH-ubiquinone oxidoreductase chain 26.07E-03B1ART2Vacuolar protein sorting 13D0.0322
Q9R0H2Endomucin1.44E-03Q6P3B2UBA-like domain-containing protein 10.0420
Q91XX1Protocadherin gamma C32.12E-04Q9R0L6Pericentriolar material 1 protein0.0284
F2Z3Y4GATOR complex protein NPRL36.24E-04Q8BZN6Dedicator of cytokinesis protein 100.0452
Top 10 upregulated in protracted femaleTop 10 upregulated in protracted male
E9QJY0Cationic amino acid transporter 20.0087Q9R0M4Podocalyxin2.92E-05
A0A286YCQ5Nidogen-2 (Fragment)0.0314E9Q968Pituitary adenylate cyclase-activating polypeptide type I receptor2.92E-05
D6RCU5ATP-binding cassette sub-family C member 120.0316P47759Neuronal vesicle trafficking-associated protein 22.92E-05
Q60675Laminin subunit alpha-20.0164Q8JZL2Melanin-concentrating hormone receptor 12.92E-05
E9Q4D0Proprotein convertase subtilisin/kexin type 60.0429Q9DCF9Translocon-associated protein subunit gamma2.92E-05
Q9D6Y4BLOC-1-related complex subunit 80.0177B2RXS4Plexin-B2 OS = Mus musculus2.92E-05
A0A494B933Protein phosphatase 1 regulatory subunit 14 (Fragment)0.0288E9PW43Predicted pseudogene 103203.50E-05
Q7TNL9Coiled-coil-helix-coiled-coil-helix domain-containing 100.0463Q8VEA4Mitochondrial intermembrane space import and assembly protein 403.50E-05
Q9D0J8Parathymosin0.0380Q80V26Golgi-resident adenosine 3′,5′-bisphosphate 3′-phosphatase4.33E-05
Q9QZD8Mitochondrial dicarboxylate carrier0.0421Q5DTL9Sodium-driven chloride bicarbonate exchanger4.33E-05
Top 10 downregulated in protracted femaleTop 10 downregulated in protracted male
F8VPZ3Ubiquitinyl hydrolase 10.0307A0A1L1STC5Guanine nucleotide-binding protein subunit beta-50.0332
A0A286YDC5Mitochondrial intermediate peptidase0.0089A0A8Q0Q6H9Steroid receptor RNA activator 10.0476
Q8BGT5Alanine aminotransferase 20.0348O35945Aldehyde dehydrogenase, cytosolic 10.0139
V9GXP8ELKS/Rab6-interacting/CAST family member 10.0443P63300Selenoprotein W OS = Mus musculus0.0248
E9Q7M2TSC22 domain family, member 20.0368E9Q448Tropomyosin alpha-1 chain0.0296
Q80WM4Hyaluronan and proteoglycan link protein 40.0342G3X8Y1Tripartite motif-containing 550.0133
Q920P3BMP/retinoic acid-inducible neural-specific protein 10.0302Q9Z0J0NPC intracellular cholesterol transporter 20.0391
Q6P5U7NACHT and WD repeat domain-containing protein 20.0100Q7M6Z4Kinesin-like protein KIF270.0132
A0A0J9YUM2Ras/Rap GTPase-activating protein SynGAP0.0393G3UWX9Small ubiquitin-related modifier 30.0493
B7ZC46Septin0.0486P08228Superoxide dismutase [Cu-Zn]0.0448

Top 10 increased and decreased proteins in the dorsolateral striatum within each sex and alcohol abstinence group.

Next, we assessed the proteome changes in the DMS. The total number of proteins that had significantly altered abundance as a result of alcohol drinking and abstinence were similar between males and females in the acute abstinence group. However, the pattern of increased abundance relative to decreased abundance were opposite between each sex. In female mice, there were 148 proteins increased and 64 proteins decreased (Figure 3A) while males had 59 increased and 171 decreased proteins (Figure 3B). In analyzing clustering of differentially abundant proteins, we saw that alcohol and water drinkers were distinctly dissimilar in both females and males (Figures 3C, D). For mice that experienced protracted abstinence, total protein abundance was lower than those that went through acute abstinence. There were 83 increased and 8 decreased proteins in females (Figure 3E), and 5 increased and 31 decreased in males (Figure 3F). Analyses of the clustering data show that protein abundances were most dissimilar between the water and alcohol groups in all animals (Figures 3G, H). Table 2 shows the top 10 increased and decreased proteins in the DMS within each sex and abstinence group.

FIGURE 3

TABLE 2

Accession #Descriptionp-valueAccession #Descriptionp-value
Top 10 upregulated in acute femaleTop 10 upregulated in acute male
P84228Histone H3.20.0101Q6P1B9Bin1 protein0.006708
Q61102Iron-sulfur clusters transporter ABCB7, mitochondrial0.0064Q8JZP2Synapsin-30.007959
Q6ZQ08CCR4-NOT transcription complex subunit 10.0088P08551Neurofilament light polypeptide0.036803
A0A1Y7VMH3Serine/threonine-protein kinase VRK10.0190P02802Metallothionein-10.037229
B1AV77Aldehyde dehydrogenase0.0126Q8R3P0Aspartoacylase0.012594
P6125560S ribosomal protein L260.0378A0A0R4J036Neurofilament medium polypeptide0.037806
P1297060S ribosomal protein L7a0.0368Q9ESM3Hyaluronan and proteoglycan link protein 20.018964
Q9CR5760S ribosomal protein L140.0372Q8BR63Protein FAM177A10.006408
Q9R0M0Cadherin EGF LAG seven-pass G-type receptor 20.0080P19246Neurofilament heavy polypeptide0.008773
B1AR17DNA helicase0.0067Q9JK88Serpin I20.010082
Top 10 downregulated in acute femaleTop 10 downregulated in acute male
B9EHT4CAP-Gly domain-containing linker protein 30.0090Q61136Serine/threonine-protein kinase PRP4 homolog0.0161
Q3U0M1Trafficking protein particle complex subunit 90.0356D3Z2V6Ras-related protein M-Ras (Fragment)0.0130
P10518Delta-aminolevulinic acid dehydratase0.0347P63213Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-20.0224
D3YWK6Thiopurine S-methyltransferase (Fragment)0.0242A2AI21Glutamate receptor0.0089
Q9DBB8Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase0.0259Q8R555Cartilage acidic protein 10.0311
Q9D711Pirin0.0312P23818Glutamate receptor 10.0124
Q3UHX228 kDa heat- and acid-stable phosphoprotein0.0302A2ALL9Calcium-transporting ATPase0.0283
B2RUG9Adenomatosis polyposis coli0.0432P0DN34NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10.0327
Q62048Astrocytic phosphoprotein PEA-150.0050Q8BG51Mitochondrial Rho GTPase 10.0450
Q8K449ATP-binding cassette sub-family A member 90.0096Q9CPR460S ribosomal protein L170.0038
Top 10 upregulated in protracted femaleTop 10 upregulated in protracted male
Q9JK88Serpin I20.0101Q61194Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha0.0388
Q8BR63Protein FAM177A10.0064B2RSY5A disintegrin and metallopeptidase domain 60.0337
P19246Neurofilament heavy polypeptide0.0088Q9CQF039S ribosomal protein L11, mitochondrial0.0132
Q9ESM3Hyaluronan and proteoglycan link protein 20.0190Q64012RNA-binding protein Raly0.0139
Q8R3P0Aspartoacylase0.0126B2RXC83222402P14Rik protein0.0298
A0A0R4J036Neurofilament medium polypeptide0.0378Q91Z38Tetratricopeptide repeat protein 10.0206
P08551Neurofilament light polypeptide0.0368D3YXK2Scaffold attachment factor B10.0278
P02802Metallothionein-10.0372Q8BIW1Exopolyphosphatase PRUNE10.0158
Q8JZP2Synapsin-30.0080Q9WV34MAGUK p55 subfamily member 20.0265
Q6P1B9Bin1 protein0.0067Q7M739Nucleoprotein TPR0.0334
Top 10 downregulated in protracted femaleTop 10 downregulated in protracted male
Q61136Serine/threonine-protein kinase PRP4 homolog0.0161P43274Histone H1.40.0256
D3Z2V6Ras-related protein M-Ras (Fragment)0.0130Q61687Transcriptional regulator ATRX0.0045
P63213Guanine nucleotide-binding protein subunit gamma-20.0224O89050Muskelin0.0410
A2AI21Glutamate receptor0.0089P10922Histone H1.00.0378
Q8R555Cartilage acidic protein 10.0311A0A0A6YWA0Histone-lysine N-methyltransferase EHMT1 (Fragment)0.0444
P23818Glutamate receptor 10.0124Q9JHJ0Tropomodulin-30.0165
A2ALL9Calcium-transporting ATPase0.0283P43276Histone H1.50.0135
P0DN34NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10.0327P43277Histone H1.30.0340
Q8BG51Mitochondrial Rho GTPase 10.0450Q9CXI02-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial0.0267
Q9CPR460S ribosomal protein L170.0038P43275Histone H1.10.0245

Top 10 increased and decreased proteins in the dorsomedial striatum within each sex and alcohol abstinence group.

The final brain region we assessed was the NAc. In mice that were exposed to acute abstinence, 230 increased and 98 decreased proteins were identified in females (Figure 4A). In males with acute abstinence, there were slightly more proteins affected with 273 increased and 154 decreased (Figure 4B). Figures 4C, D show a similar pattern as in the DMS with water and alcohol drinking largely driving the clustering. Female mice that were exposed to protracted abstinence had 322 increased and 121 decreased proteins (Figure 4E). However, the total amount of significantly abundant proteins in males was much lower, with 10 being increased and 39 decreased (Figure 4F). Figures 4G, H show that alcohol and water drinking were most dissimilar in males and females. The top increased and decreased proteins within each sex and abstinence group can be found in Table 3.

FIGURE 4

TABLE 3

Accession #Descriptionp-valueAccession #Descriptionp-value
Top 10 Upregulated in Acute FemaleTop 10 upregulated in acute male
Q3TXX4Vesicular glutamate transporter 10.0415Q91Z49UAP56-interacting factor0.0461
Q3UHL1CaM kinase-like vesicle-associated protein0.0362Q80TN5Palmitoyltransferase ZDHHC170.0086
Q5DQR4Syntaxin-binding protein 5-like0.0188Q8R0W0Epiplakin0.0315
Q9CQW2ADP-ribosylation factor-like protein 8B0.0219Q8CAL5Glypican-50.0050
P6224540S ribosomal protein S15a0.0046Q64378Peptidyl-prolyl cis-trans isomerase FKBP50.0475
B2RWC4Gm88 protein0.0103Q8BHC4Dephospho-CoA kinase domain-containing protein0.0430
Q9QXG2Rab proteins geranylgeranyltransferase component A 10.0449B7ZCF4Lysosomal acid phosphatase (Fragment)0.0448
D3YVU3Centrosomal protein of 164 kDa0.0245Q62313Trans-Golgi network integral membrane protein 10.0223
D3Z5I9RNA-binding protein 330.0105Q8BYW9EGF domain-specific O-linked N-acetylglucosamine transferase0.0239
Q6GQS1Calcium-binding mitochondrial carrier protein SCaMC-30.0166Q9QWW1Homer protein homolog 20.0454
Top 10 downregulated in acute femaleTop 10 downregulated in acute male
A0A498WGR4Galanin peptides0.0112E9PZ08FYN-binding protein 20.0149
P97825Jupiter microtubule associated homolog 10.0168F6VCP8FLYWCH family member 2 (Fragment)0.0284
G3UW82Myosin, heavy polypeptide 2, skeletal muscle, adult0.0024Q9WUE4GATOR complex protein NPRL20.0281
Q8BK7228S ribosomal protein S27, mitochondrial0.0218A0A0N4SVP9SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-containing DEAD/H box 1 (Fragment)0.0027
F6RPX5Alpha-tubulin N-acetyltransferase 1 (Fragment)0.0316Q6P1B9Bin1 protein0.0445
P20934Protein EVI2A0.0112P09240Cholecystokinin0.0019
P09240Cholecystokinin0.0154Q8BG58Transmembrane prolyl 4-hydroxylase0.0471
Q06138Calcium-binding protein 390.0115Q6W8Q3Purkinje cell protein 4-like protein 10.0261
Q9DD18D-aminoacyl-tRNA deacylase 10.0010Q9D735Telomerase RNA component interacting RNase0.0189
A2A4A61-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma0.0062Q60698Ski oncogene0.0278
Top 10 Upregulated in protracted femaleTop 10 upregulated in protracted male
P39429TNF receptor-associated factor 20.0328P80313T-complex protein 1 subunit eta0.0372
E9Q3B2Pogo transposable element with KRAB domain0.0180Q8BFZ9Erlin-20.0283
Q9DC07LIM zinc-binding domain-containing Nebulette0.0237P35700Peroxiredoxin-10.0497
F7CPX0SH3-containing GRB2-like protein 3-interacting protein 1 (Fragment)0.0095A2ARZ3Fibrous sheath-interacting protein 20.0172
F6T8K1Izumo sperm-egg fusion protein 3 (Fragment)0.0196Q6ZWQ5Sorting nexin-120.0267
Q99PV8B-cell lymphoma/leukemia 11B0.0109P04925Major prion protein0.0175
P35487Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial0.0311P61226Ras-related protein Rap-2b0.0370
A0A571BET0Voltage-dependent P/Q-type calcium channel subunit alpha0.0111D3YXK2Scaffold attachment factor B10.0433
Q8BJR7Centrosomal protein of 97 kDa0.0268Q5SUV9Aromatic-L-amino-acid decarboxylase (Fragment)0.0071
E9Q350BAI1-associated protein 30.0097B0QZN5Vesicle-associated membrane protein 20.0491
Top 10 downregulated in protracted femaleTop 10 downregulated in protracted male
Q8BTF8RNA-binding Raly-like protein0.0022Q80Y14Glutaredoxin-related protein 5, mitochondrial0.0053
E9Q1K3Alpha-adducin0.0386A0A338P7E5Ubiquitin-conjugating enzyme E2 L30.0077
P83887Tubulin gamma-1 chain0.0023Q3U422NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial0.0139
Q9JHR7Insulin-degrading enzyme0.0023P20065Thymosin beta-40.0077
O08582GTP-binding protein 10.0026P28184Metallothionein-30.0401
P56388Cocaine- and amphetamine-regulated transcript protein0.0147P54227Stathmin0.0152
Q80VQ0Aldehyde dehydrogenase family 3 member B10.0089Q9DBR7Protein phosphatase 1 regulatory subunit 12A0.0439
D6REG4Glyoxylate reductase/hydroxypyruvate reductase0.0194P61148Fibroblast growth factor 10.0138
Q9CRD4Dysbindin domain-containing protein 20.0048Q91XU3Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma0.0065
A0A1Y7VN19Dehydrogenase/reductase SDR family member 7 (Fragment)0.0178P6224240S ribosomal protein S80.0242

Top 10 increased and decreased proteins in the nucleus accumbens within each sex and alcohol abstinence group.

Overlap analyses shows distinct protein changes between striatal subregions and abstinence lengths

To determine if there were overlapping proteins between each sex and abstinence period within each brain region, we compared all significantly abundant proteins within each of the DLS, DMS and NAc regions (Figures 5A–C; Table 4). There was no protein within any brain region that was commonly affected between each sex and abstinence period. In the DLS, there were 11 overlapping proteins between acute abstinence males and females, and 2 between protracted abstinence males and females. In the DMS, 19 overlapping proteins were identified between acute abstinence males and females and 2 between protracted mice. Finally, in the NAc, there were 39 overlapping proteins between acute abstinence groups and 2 overlapping proteins between protracted groups.

FIGURE 5

TABLE 4

DLSDMSNAc
Protracted femaleAcuteProtracted femaleAcuteProtracted femaleAcute
Vs. MaleFemale Vs. MaleVs. MaleFemale Vs. MaleVs. MaleFemale Vs. Male
Slc25a10Coa3Rps6Atp8a1PtnNapbDnm1Dhrs4Thoc7Rab2a
Hdhd2Sars2Sart1Rpl38Cfl1Fgf1Pgm2l1CaskDnm1lCck
Fth1Negr1Exoc8Camk1dPyurfMpripCadm1
Trip4Rab5bDclk2Ddx46ThtpaBckdhaRasa3
GaleKcnd2Sbf1Cox6a1Strn4TfgDcps
Fkbp5Lrp1Rps19Ak1Cox6b1Nme2Czib
Pqbp1GkAifm1Rps28ShflCrtc1
Cdk5Rps14Skp1Nars1RabifGrpel1
Arih2Rps11Dctn6BadCtnnd2
Camk1Nomo1Acp1Rras2Rgs7
NecapAk1Rpl15Atp6v1fUbe2m

Overlapping protein abundance in striatal subregions.

Biological process and pathway analyses reveal sex and abstinence length effects of alcohol exposure in the DLS, DMS and NAc

To further investigate proteins that were affected by alcohol drinking followed by abstinence, we conducted a gene ontology analysis for biological processes. The first brain region we looked at was the DLS. For mice exposed to acute abstinence, 464 biological processes were affected in females and 3 in males. For those exposed to protracted abstinence, 469 biological processes were modified in females and 1,051 in males. The top biological processes (p < 0.05) in the DLS are displayed in Table 5.

TABLE 5

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted maleProtracted female
Regulation of transport2.31E-29Central nervous system development3.43E-11
Vesicle-mediated transport3.04E-27Small molecule metabolic process9.91E-10
Establishment of protein localization1.32E-26Organonitrogen compound biosynthetic process1.02E-09
Intracellular transport2.85E-26Positive regulation of protein localization1.21E-08
Positive regulation of cellular component organization3.46E-23Protein transport1.88E-08
Membrane organization1.24E-21Purine-containing compound metabolic process3.23E-08
Protein transport3.48E-21Neuron projection development3.61E-08
Plasma membrane bounded cell projection organization5.08E-21Localization within membrane3.61E-08
Cell projection organization7.09E-21Plasma membrane bounded cell projection organization3.64E-08
Cell junction organization3.97E-20Energy derivation by oxidation of organic compounds4.00E-08
Acute maleAcute female
Positive regulation of protein metabolic process0.00154Vesicle-mediated transport1.38E-16
Establishment of protein localization2.85E-15
Protein transport4.11E-15
Organonitrogen compound biosynthetic process6.98E-13
Cell junction organization2.57E-12
Localization within membrane4.16E-11
Neuron projection development6.79E-11
Amide biosynthetic process1.42E-10
Synapse organization1.42E-10
Cellular component morphogenesis3.10E-10

Top 10 biological processes in the DLS.

Only biological processes with an adjusted p-value < 0.05 are shown.

In the DMS, 980 biological processes were affected in acute females, 1,344 in acute males, 140 in protracted females, and 452 in protracted males. In the NAc, 871 processes were significantly modified in acute females, 873 in acute males, 1,435 in protracted females, and 918 in protracted males. Tables 6, 7 list the top 10 processes in the DMS and NAc respectively. We used the online tool Revigo to simplify the lengthy list of biological processes. The simplified lists for each striatal subregion and abstinence length can be found in the Supplementary Material. We also assessed overlapping biological processes between striatal subregions and lengths of abstinence. In the DLS, 1 process was found to overlap between acute males, protracted males and protracted females and 170 between acute females, protracted females and protracted males (Figure 5D). In the DMS, 1 biological process was found to overlap all groups (Figure 5E). Finally, 51 processes were found to overlap all groups in the NAc (Figure 5F). Overlapping biological processes can be found in Supplementary Table S2.

TABLE 6

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted maleProtracted female
Nucleosome assembly1.61E-10Cytoplasmic translation5.69E-12
Nucleosome organization4.57E-10Peptide metabolic process7.85E-10
Chromosome condensation5.76E-09Amide metabolic process1.26E-08
Negative regulation of DNA recombination1.00E-08Translation at postsynapse7.56E-08
Protein-DNA complex assembly2.51E-08Translation at synapse7.56E-08
Chromatin remodeling3.90E-08Translation at presynapse7.56E-08
Chromatin organization2.04E-07Translation8.13E-08
Heterochromatin organization4.95E-07Peptide biosynthetic process1.15E-07
Protein-DNA complex organization5.03E-07Amide biosynthetic process1.24E-07
Regulation of DNA recombination1.99E-06Ribosome biogenesis1.54E-05
Acute maleAcute female
Cytoplasmic translation3.22E-18Cytoplasmic translation1.98E-14
Cellular localization3.22E-18Translation at presynapse3.66E-14
Cellular component organization or biogenesis3.22E-18Translation at synapse3.66E-14
Localization2.37E-17Translation at postsynapse3.66E-14
Cellular component organization1.54E-16Amide biosynthetic process2.32E-10
Organelle organization9.36E-16Translation4.02E-10
Establishment of localization2.38E-14Peptide biosynthetic process7.32E-10
Transport2.63E-13Amide metabolic process2.20E-09
Regulation of biological quality9.91E-13Peptide metabolic process3.91E-09
Regulation of localization1.58E-12Organonitrogen compound biosynthetic process1.28E-08

Top 10 biological processes in the DMS.

Only biological processes with an adjusted p-value < 0 .05 are shown.

TABLE 7

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted MaleProtracted female
Regulation of cellular component biogenesis0.00032Cellular component organization or biogenesis1.41E-24
Regulation of protein-containing complex assembly0.00100Localization1.92E-24
Negative regulation of supramolecular fiber organization0.00404Organelle organization2.92E-24
Negative regulation of cytoskeleton organization0.00404Cellular localization2.52E-23
Regulation of synaptic vesicle priming0.00620Cellular component organization2.67E-23
Regulation of protein polymerization0.00620Establishment of localization6.26E-23
Synaptic vesicle cycle0.00659Transport6.83E-23
Actin filament organization0.00678Cell junction organization1.42E-20
Negative regulation of protein polymerization0.00808Establishment of localization in cell4.45E-20
Protein-containing complex disassembly0.00808Regulation of cellular component organization1.91E-19
Acute maleAcute female
Cytoplasmic translation1.33E-23Organelle organization9.10E-16
Organonitrogen compound metabolic process5.06E-22Cellular localization3.52E-15
Translation5.50E-19Localization1.21E-13
Peptide biosynthetic process1.31E-18Organonitrogen compound metabolic process1.03E-12
Protein metabolic process1.31E-18Establishment of localization in cell1.34E-12
Peptide metabolic process1.31E-18Establishment of localization9.67E-12
Cellular localization3.23E-17Transport7.93E-11
Establishment of localization in cell9.56E-17Cellular component organization or biogenesis8.34E-11
Amide biosynthetic process1.40E-16Protein localization2.03E-10
Cellular process4.68E-16Cellular component organization2.03E-10

Top 10 biological processes in the NAc.

Only biological processes with an adjusted p-value < 0.05 are shown.

We next investigated further to assess the biological pathways that significant overlapping proteins were involved in. We conducted this search using the KEGG biological pathways database. This revealed that there were pathways enriched by alcohol consumption followed by acute and protracted abstinence. In the DLS, 15 pathways were affected in acute females, 10 in acute males, 11 in protracted females and 25 in protracted males. The top 10 biological pathways in the DLS are displayed in Table 8. Overlapping biological pathways were also identified. In the DLS, 6 pathways overlapped between the protracted males and females and acute females and 3 between acute and protracted females (Figure 5G; Supplementary Table S3). We conducted the same search in the DMS and saw that less biological pathways were affected in all groups except acute males, when compared to the DLS. In the DMS, 2 process were affected in acute females, 18 in acute males, 4 in protracted females, and 1 in protracted males. The top 10 biological pathways in the DMS are displayed in Table 9. Only 2 pathways were found to overlap between protracted females, and acute males and females (Figure 5H; Supplementary Table S3). The final assessment was done in the NAc, where we saw 17 enriched processes in acute females, 5 in acute male, 56 in protracted females, and 2 in protracted males. The top biological pathways in the NAc are displayed in Table 10. 2 pathways were found to overlap between protracted males and females, and 3 between protracted females and acute males (Figure 5I; Supplementary Table S3).

TABLE 8

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted maleProtracted female
Endocrine and other factor-regulated calcium reabsorption4.53E-05Pathways of neurodegeneration— multiple diseases0.00059
Adrenergic signaling in cardiomyocytes4.53E-05Huntington disease0.00059
Parkinson disease1.30E-04Carbon metabolism0.00105
SNARE interactions in vesicular transport1.30E-04Parkinson disease0.00105
Pathways of neurodegeneration—multiple diseases1.32E-04Amyotrophic lateral sclerosis0.00105
Salivary secretion1.65E-04Oxidative phosphorylation0.00166
Mineral absorption1.69E-04Metabolic pathways0.00224
Mitophagy—animal2.33E-04Diabetic cardiomyopathy0.00574
Amyotrophic lateral sclerosis2.33E-04Alzheimer disease0.00704
Synaptic vesicle cycle6.21E-04Prion disease0.00704
Acute femaleAcute male
Parkinson disease2.10E-05No significant pathways identified
Pathways of neurodegeneration—multiple diseases7.14E-05
Huntington disease1.00E-04
Amyotrophic lateral sclerosis1.11E-04
Oxidative phosphorylation1.23E-04
Diabetic cardiomyopathy5.40E-04
Alzheimer disease1.10E-03
Metabolic pathways1.16E-03
Prion disease1.54E-03
Thermogenesis1.54E-03

Top 10 KEGG pathways in the DLS.

Only KEGG pathways with an adjusted p-value < 0.05 are shown.

TABLE 9

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted maleProtracted female
Nucleocytoplasmic transport0.0388Ribosome4.53E-09
Coronavirus disease—COVID-191.44E-07
Acute maleAcute female
Ribosome4.39E-07Ribosome8.39E-10
Coronavirus disease—COVID-196.12E-06Coronavirus disease—COVID-191.19E-06
Huntington disease4.08E-04
Endocrine and other factor-regulated calcium reabsorption1.36E-03
Glutamatergic synapse1.47E-03
Alcoholism4.77E-03
Systemic lupus erythematosus6.90E-03
Pathways of neurodegeneration—multiple diseases1.01E-02
Cocaine addiction1.47E-02
Synaptic vesicle cycle1.68E-02

Top 10 KEGG pathways in the DMS.

Only KEGG pathways with an adjusted p-value < 0 .05 are shown.

TABLE 10

DescriptionAdjusted p-valueDescriptionAdjusted p-value
Protracted maleProtracted female
Regulation of actin cytoskeleton0.0496Non-alcoholic fatty liver disease2.92E-05
Pathways of neurodegeneration - multiple diseases0.0496Thermogenesis2.92E-05
Oxidative phosphorylation2.92E-05
Parkinson disease2.92E-05
Amyotrophic lateral sclerosis2.92E-05
Prion disease2.92E-05
Ras signaling pathway3.50E-05
Retrograde endocannabinoid signaling3.50E-05
Pathways of neurodegeneration—multiple diseases4.33E-05
Diabetic cardiomyopathy4.33E-05
Acute maleAcute female
Ribosome2.48E-11No significant pathways identified
Coronavirus disease—COVID-195.20E-08
Spliceosome1.90E-04
Huntington disease4.01E-02

Top 10 KEGG pathways in the NAc.

Only KEGG pathways with an adjusted p-value < 0.05 are shown.

Discussion

Using this model of chronic intermittent two-bottle choice alcohol drinking in adult mice, we identified many differences in striatal protein abundance as a function of sex, duration of alcohol abstinence and striatal subregion. It is important to note that this model of drinking is not directly associated with producing alcohol dependence. We found that this model of alcohol drinking caused females to drink more alcohol than males, which is consistent with work from other studies, including our own (Hwa et al., 2011; Grecco et al., 2022). One limitation of our study is that we did not track blood alcohol levels. Others who have used a similar model have reported that our model produces BECs ranging from 79.58 to 166.93 mg/dL (Hwa et al., 2011). Though we did not find a sex effect on alcohol preference, female mice have been shown to display a greater preference for 20% alcohol than males with less sex differences at lower concentrations (Rivera-Irizarry et al., 2023). However, we have recently tested a model of binge-like alcohol drinking and found that males and females consumed similar levels of alcohol (Haggerty and Atwood, 2024). The differences in the sex effects between these studies may be a result of the type of access the mice had. Females also consumed more water than males, but the difference in amount was not as pronounced as seen with alcohol consumption. For this reason, we do not believe this difference in alcohol consumption was due to overall increased fluid consumption in females.

If we focus solely on the numbers of proteins with differential abundance because of alcohol drinking and different durations of abstinence, we find some interesting sex- and striatal subregion-dependent outcomes. In the DLS, females with acute abstinence and males with protracted abstinence displayed the greatest total changes in protein abundance. In contrast, in the DMS, acute abstinence produced more changes than protracted abstinence in both males and females. The total number of proteins affected were more modest than any of the changes seen in the DLS. In the NAc, both acute and protracted alcohol abstinence produced abundant changes in protein abundance in females, while protein abundance changes in males were largely restricted to acute abstinence. Taken together it appears that in males, acute abstinence produces the greatest changes in NAc and DMS, but over the course of protracted abstinence, protein abundance in these regions normalizes and changes in protein abundance shift to the DLS. In contrast, in females it appears that acute abstinence consistently produces protein abundance changes in all 3 striatal subregions, but the greatest change during protracted abstinence is in the NAc with very little effects in the DLS, which is the opposite of what is seen in males. Thus, the pattern of striatal protein abundance change in males and females appears to shift in spatially opposite directions. This is interesting as it has been reported that over the course of alcohol drinking, behavioral control of drinking shifts from ventromedial striatum to DLS (Willuhn et al., 2012; Bell et al., 2016). If we consider changes in protein abundance as a proxy for this control, then our data in males reflects this pattern, whereas in females it would be opposite. Of course, changes in protein abundance could just as well mediate a decrease in functional control as an increase. Much work will need to be done to link the changes in protein abundance seen here to changes in control over drinking behavior. We would also like to note that further work would be needed to isolate alterations that are due to alcohol intake versus differences in sensitivity to alcohol due to biological differences.

According to our hypothesis, we expected to see a significant change in the abundance of neuroinflammatory-related protein between drinking groups. Based on our prior work in adolescent rats, we specifically anticipated finding significant changes to the inflammatory-associated proteins endothelin-1 (ET-1), COX-2, and PGE2 in the dorsal striatum (Kline and Yamamoto, 2022). However, we did not identify significant alterations to these proteins in either of the DS subregions (DLS or DMS) even though we added probes for these to enhance detection during mass spectrometry. Not only did we not detect changes in the abundance of these proteins, our gene ontology and KEGG pathway assessments did not reveal a significant effect on any inflammation-related protein abundance. This was surprising to us. There are some potential explanations to account for this discrepancy. The most obvious difference is that we used mice here, whereas our previous work used rats (Kline and Yamamoto, 2022). Some studies show that there are distinct differences in components of the immune response between mice and rats, including variations in microglia function and chemokine release in neurons (Patrizio and Levi, 1994; Du et al., 2017; Lam et al., 2017). In addition, here the animals were adults when they started alcohol consumption, whereas our previous work used adolescents (Kline and Yamamoto, 2022). It is also possible that we did not identify the neuroinflammatory changes we expected to see due to the mice not consuming sufficient amounts, especially the males. Furthermore, several of the proteins had never been previously identified using mass spectrometry and are present at challenging to identify levels. Some proteins may also be changing in localization, splicing, or post translational modifications which we would not be able to identify in this study. Despite these species and age differences though, we still expected to see some changes in these inflammation pathways, even if it was not the same proteins that were affected. These discrepancies may be a product of the timing at which tissue samples were taken as our prior study did not find any differences in inflammation-related proteins early in abstinence, but these appeared over protracted abstinence. It is possible that in mice it takes longer for the abundance of these inflammation proteins to change.

Nevertheless, we conducted a PubMed database analysis of the overlapping proteins between protracted and acute abstinence males and females of each brain region (Figure 5) to identify any inflammatory-related role. From this search, we identified one neuroinflammatory-related protein that was significantly altered in both females with protracted abstinence and males with acute abstinence, Cluster of Differentiation CD200. CD200 is a key mediator of the innate immune response and neuroinflammation. It has also been shown to decrease in protein abundance in response to alcohol consumption in humans but increase during alcohol abstinence (Chaturvedi et al., 2020).

We investigated whether any of the proteins with significantly altered abundance were similarly altered in more than one group. We found very little overlap between all sex and abstinence groups within each striatal subregion. Focusing on similarities between sexes within each subregion, we found only 2 overlapping proteins in the protracted abstinence groups, but quite a few overlaps between sexes in the acute abstinence groups. These data suggest that alcohol drinking may produce some overlapping biological outcomes in both sexes, but over time these outcomes may diverge greatly. Nonetheless, in assessing what proteins are similarly affected in males and females, we identified some proteins relevant to alcohol. In the DLS, Fkbp5 was common to male and female mice that experienced acute abstinence. Fkbp5 is a glucocorticoid receptor binding protein that plays a strong role in psychiatric disorders and is induced by stress (Szymanska et al., 2009). The Fkbp5 gene can also be induced by alcohol as shown by its increased expression following acute alcohol injections (Kerns et al., 2005; Qiu et al., 2016). Furthermore, Fkbp5 knockout mice show increased alcohol consumption and blood alcohol levels compared to wildtype (Qiu et al., 2016). In addition to playing a role in alcohol consumption in mice, Fkbp5 was also identified as a potential key gene in human alcohol consumption. SUMO-conjugating enzyme UBC9 was common to male and female mice that underwent protracted abstinence as well as male drinkers that experienced acute abstinence. Similarly, UBC9 is tied to alcohol consumption as it plays a role in alcohol-induced liver damage (Tomasi et al., 2012; Tomasi et al., 2018). In the DMS, we identified proteasome 26S subunit, ATPase 1 (PSMC1), which was significantly altered in acute females and protracted males. PSMC1 displays decreased expression in liver tissue in response to alcohol treatment in mice. Decreased expression of PMSC1 is also identified in the livers of individuals who suffered from alcohol use disorder compared to healthy livers (Wang et al., 2016). Its role in the striatum is unknown. Our analysis of the NAc did not reveal any proteins that overlapped in drinking groups that were strongly linked to alcohol drinking. Additional study of the proteins we identified in these overlaps may produce new knowledge regarding the effects of alcohol on the brain that are common to both sexes.

We identified many biological process gene ontology terms that were affected by alcohol drinking and different lengths of abstinence. To aid in the interpretation of these data, we simplified our list based on term similarity using the Revigo online tool, to better elucidate the cellular functions and processes that were altered. This allowed us to cluster terms according to their cellular functions and their uniqueness (relative to the entire list of terms). We were able to do this for all groups except the DLS of males that underwent acute abstinence due to the limited number of significantly altered biological processes identified. As expected, brain development was one of the major clusters across all groups, which included processes such as neurogenesis, axonogenesis, neuron differentiation and many other neural development processes. Additionally, we were intrigued to see many processes related to synapse organization, chemical synaptic transmission, intracellular transport, and cytoskeleton organization that were common to all striatal subregions. In the DLS unique clusters included regulation of intracellular transduction, cell migration, cellular homeostasis, chemical synaptic transmission, and regulation of cellular component organization. In the DMS, unique clusters included mitochondrion localization, lipid modification and regulation of RNA export. Lastly, we saw major unique terms related to peptide metabolic processes, regulation of macromolecule localization, and apoptotic processes in the NAc.

A general feature across striatal subregions, sexes, and durations of alcohol abstinence are changes related to proteins that function to transport biological materials within cells, organization of cellular structure, and protein translation processes. These data would indicate that alcohol’s physiological and behavioral effects may be mediated by biochemical mechanisms that reorganize the structure and composition of striatal cells and in particular neurons. This is an important point to make as much current work in the field is focused on changes in mRNA transcription. Changes in the localization of proteins as well as in translation processes will likely not be detected using transcriptomic methodologies. For instance, the reduction of key organization proteins such as α- and β-tubulin and associated proteins is identified in brains of individuals with chronic alcohol consumption and rodents (Labisso et al., 2018). However, a slight increase was seen in tubulin gene expression. This further speaks to the relevance of assessing changes in translation due to the effects of alcohol. Furthermore, the trafficking of crucial components such as neurotransmitter receptors is modified by chronic alcohol consumption (Shen et al., 2011). In addition, studies of the structure of neurons will also be especially important. Indeed, studies show that alcohol-induced apoptosis disrupts neural plasticity (Toesca et al., 2003; Do et al., 2013). The effects on alcohol on neuronal developing is rather vast, and is known to also disrupt neurogenesis (Tateno and Saito, 2008).

Even though our gene ontology and pathway enrichment analyses did not find strong links to inflammation, some of our analyses pointed to changes in proteins related to neurodegenerative diseases, including Alzheimer disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson disease. We identified changes related to neurodegenerative diseases in the DLS and NAc, but not DMS, striatal subregions of both males and females that underwent protracted alcohol abstinence. We did not identify any link to these diseases in females with acute abstinence, but found some neurodegeneration-related changes in all striatal subregions of males with acute abstinence. These data would imply that alcohol consumption starts changes to protein pathways that lead to eventual neurodegeneration that begins early on in males that drink but develops more slowly in females over the course of a protracted abstinence period. Additional experimentation will be needed to see if this is a function of how much alcohol is consumed and for how long that consumption occurred over time. There has been an increased interest in the links between alcohol drinking and neurodegeneration in recent years (Kelso et al., 2011; Qin and Crews, 2012; Crews et al., 2015; Crews and Vetreno, 2016). While we did not find changes in the abundance of many specific inflammatory proteins, a key characteristic of many neurogenerative conditions is a neuroinflammatory response. Due to the strong relationship between these diseases and neuroinflammation, the neurogenerative pathways identified during this study may indicate that some sort of neurodegenerative inflammatory-related process may play a role in alcohol drinking and abstinence.

Overall, this study reveals many new candidate proteins to explore for how alcohol affects the brain to promote further alcohol use, and even possibly compulsive or habitual alcohol use. It reveals many differences between sexes as well as some overlapping targets between sexes. Further work is needed to determine why we observed changes in inflammation related protein abundances in prior work but failed to see similar outcomes here. However, our data implicate alcohol-induced changes in neurodegeneration-associated proteins and proteins involved in cellular transport, protein translation, and cellular structure that may also play a role in alcohol-induced deficits in brain health.

Statements

Data availability statement

The data presented in the study are deposited in a GitHub library at this link: https://github.com/bduffus/Chronic-Alcohol-Withdrawal-Proteome.

Ethics statement

The animal study was approved by the Indiana University School of Medicine IACUC. The study was conducted in accordance with local and national legislation and guidelines and also institutional requirements.

Author contributions

BD: Data curation, Formal Analysis, Visualization, Writing–original draft, Writing–review and editing. DH: Methodology, Writing–review and editing. ED: Conceptualization, Formal Analysis, Investigation, Methodology, Resources, Writing–original draft, Writing–review and editing. AM: Resources, Supervision, Writing–review and editing. BY: Funding acquisition, Supervision, Writing–review and editing. BA: Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Supervision, Writing–original draft, Writing–review and editing.

Funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. The animal experiments and data analysis work were supported by funding from the National Institutes of Health, National Institute on Drug Abuse, R01 DA042737. The mass spectrometry work performed in this work was done by the Indiana University School of Medicine Proteomics Core. Acquisition of the IUSM Proteomics core instrumentation used for this project was provided by the Indiana University Precision Health Initiative. The proteomics work was supported, in part, by the Indiana Clinical and Translational Sciences Institute (funded in part by Award Number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award) and, in part, by the IU Simon Comprehensive Cancer Center Support Grant (Award Number P30CA082709 from the National Cancer Institute).

Acknowledgments

We would like to thank Whitney Smith-Kinnaman for all of their help with performing the proteomics experiments.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2024.1405446/full#supplementary-material

References

  • 1

    AlcoholismN. I. o.A. A. a.2024Medications development program. Available at: https://www.niaaa.nih.gov/medications-development-program.

  • 2

    BalleineB. W.O DohertyJ. P. (2010). Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology35 (1), 4869. 10.1038/npp.2009.131

  • 3

    BellR. L.HauserS. R.McClintickJ.RahmanS.EdenbergH. J.SzumlinskiK. K.et al (2016). Ethanol-associated changes in glutamate reward neurocircuitry: a minireview of clinical and preclinical genetic findings. Prog. Mol. Biol. Transl. Sci.137, 4185. 10.1016/bs.pmbts.2015.10.018

  • 4

    BlakerA. L.YamamotoB. K. (2018). Methamphetamine-induced brain injury and alcohol drinking. J. Neuroimmune Pharmacol.13 (1), 5363. 10.1007/s11481-017-9764-3

  • 5

    BlochS.RinkerJ. A.MarcusM. M.MulhollandP. J. (2020). Absence of effects of intermittent access to alcohol on negative affective and anxiety-like behaviors in male and female C57BL/6J mice. Alcohol88, 9199. 10.1016/j.alcohol.2020.07.011

  • 6

    ChaturvediA.RaoG.PraharajS. K.GuruprasadK. P.PaisV. (2020). Reduced serum levels of cluster of differentiation 200 in alcohol-dependent patients. Alcohol Alcohol55 (4), 391394. 10.1093/alcalc/agaa033

  • 7

    CorbitL. H.NieH.JanakP. H. (2012). Habitual alcohol seeking: time course and the contribution of subregions of the dorsal striatum. Biol. Psychiatry72 (5), 389395. 10.1016/j.biopsych.2012.02.024

  • 8

    CrewsF. T.ColemanL. G.JrMachtV. A.VetrenoR. P. (2023). Targeting persistent changes in neuroimmune and epigenetic signaling in adolescent drinking to treat alcohol use disorder in adulthood. Pharmacol. Rev.75 (2), 380396. 10.1124/pharmrev.122.000710

  • 9

    CrewsF. T.SarkarD. K.QinL.ZouJ.BoyadjievaN.VetrenoR. P. (2015). Neuroimmune function and the consequences of alcohol exposure. Alcohol Res.37 (2), 331341.

  • 10

    CrewsF. T.VetrenoR. P. (2016). Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacol. Berl.233 (9), 15431557. 10.1007/s00213-015-3906-1

  • 11

    DesiereF.DeutschE. W.KingN. L.NesvizhskiiA. I.MallickP.EngJ.et al (2006). The PeptideAtlas project. Nucleic Acids Res.34, D655D658. 10.1093/nar/gkj040

  • 12

    DoH.ParkH. J.SohnE. H.KimB. O.UmS. H.KwakJ. H.et al (2013). Ethanol induces cell cycle arrest and triggers apoptosis via Sp1-dependent p75NTR expression in human neuroblastoma cells. Cell Biol. Toxicol.29 (5), 365380. 10.1007/s10565-013-9260-3

  • 13

    DuY.DengW.WangZ.NingM.ZhangW.ZhouY.et al (2017). Differential subnetwork of chemokines/cytokines in human, mouse, and rat brain cells after oxygen-glucose deprivation. J. Cereb. Blood Flow. Metab.37 (4), 14251434. 10.1177/0271678X16656199

  • 14

    EvertD. L.Oscar-BermanM. (1995). Alcohol-related cognitive impairments: an overview of how alcoholism may affect the workings of the brain. Alcohol Health Res. World19 (2), 8996.

  • 15

    Fernandez-LizarbeS.MontesinosJ.GuerriC. (2013). Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J. Neurochem.126 (2), 261273. 10.1111/jnc.12276

  • 16

    Flores-BastiasO.KarahanianE. (2018). Neuroinflammation produced by heavy alcohol intake is due to loops of interactions between Toll-like 4 and TNF receptors, peroxisome proliferator-activated receptors and the central melanocortin system: a novel hypothesis and new therapeutic avenues. Neuropharmacology128, 401407. 10.1016/j.neuropharm.2017.11.003

  • 17

    GreccoG. G.Di PriscoG. V.DoudE. H.FritzB. M.MaulucciD.AtwoodB. K.et al (2022). Prenatal opioid exposure enhances responsiveness to future drug reward and alters sensitivity to pain: a review of preclinical models and contributing mechanisms. eNeuro9 (2), 10.1523/ENEURO.0119-22.2022

  • 18

    GreccoG. G.HaggertyD. L.DoudE. H.FritzB. M.YinF.HoffmanH.et al (2021). A multi-omic analysis of the dorsal striatum in an animal model of divergent genetic risk for alcohol use disorder. J. Neurochem.157 (4), 10131031. 10.1111/jnc.15226

  • 19

    GreccoG. G.HaggertyD. L.ReevesK. C.GaoY.MaulucciD.AtwoodB. K. (2022). Prenatal opioid exposure reprograms the behavioural response to future alcohol reward. Addict. Biol.27 (2), e13136. 10.1111/adb.13136

  • 20

    GremelC. M.CostaR. M. (2013). Orbitofrontal and striatal circuits dynamically encode the shift between goal-directed and habitual actions. Nat. Commun.4, 2264. 10.1038/ncomms3264

  • 21

    HaggertyD. L.AtwoodB. K. (2024). Sex-dependent, lateralized engagement of anterior insular cortex inputs to the dorsolateral striatum in binge alcohol drinking. bioRxiv, 10.1101/2023.08.23.554484

  • 22

    HaggertyD. L.GreccoG. G.HuangJ. Y.DoudE. H.MosleyA. L.LuH. C.et al (2023). Prenatal methadone exposure selectively alters protein expression in primary motor cortex: implications for synaptic function. Front. Pharmacol.14, 1124108. 10.3389/fphar.2023.1124108

  • 23

    HaggertyD. L.MunozB.PenningtonT.Viana Di PriscoG.GreccoG. G.AtwoodB. K. (2022). The role of anterior insular cortex inputs to dorsolateral striatum in binge alcohol drinking. Elife11, e77411. 10.7554/eLife.77411

  • 24

    HeJ.CrewsF. T. (2008). Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol.210 (2), 349358. 10.1016/j.expneurol.2007.11.017

  • 25

    HwaL. S.ChuA.LevinsonS. A.KayyaliT. M.DeBoldJ. F.MiczekK. A. (2011). Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin. Exp. Res.35 (11), 19381947. 10.1111/j.1530-0277.2011.01545.x

  • 26

    KelsoM. L.LiputD. J.EavesD. W.NixonK. (2011). Upregulated vimentin suggests new areas of neurodegeneration in a model of an alcohol use disorder. Neuroscience197, 381393. 10.1016/j.neuroscience.2011.09.019

  • 27

    KernsR. T.RavindranathanA.HassanS.CageM. P.YorkT.SikelaJ. M.et al (2005). Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J. Neurosci.25 (9), 22552266. 10.1523/JNEUROSCI.4372-04.2005

  • 28

    KlineH. L.YamamotoB. K. (2022). Alcohol reinstatement after prolonged abstinence from alcohol drinking by female adolescent rats: roles of cyclooxygenase-2 and the prostaglandin E(2) receptor 1. Drug Alcohol Depend.236, 109491. 10.1016/j.drugalcdep.2022.109491

  • 29

    KoobG. F.Le MoalM. (1997). Drug abuse: hedonic homeostatic dysregulation. Science278 (5335), 5258. 10.1126/science.278.5335.52

  • 30

    KoobG. F.VolkowN. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology35 (1), 217238. 10.1038/npp.2009.110

  • 31

    LabissoW. L.RaulinA. C.NwiduL. L.KoconA.WayneD.ErdozainA. M.et al (2018). The loss of α- and β-tubulin proteins are a pathological hallmark of chronic alcohol consumption and natural brain ageing. Brain Sci.8 (9), 175. 10.3390/brainsci8090175

  • 32

    LamD.LivelyS.SchlichterL. C. (2017). Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K(+) channels and migration. J. Neuroinflammation14 (1), 166. 10.1186/s12974-017-0941-3

  • 33

    LevasseurE. M.YamadaK.PiñerosA. R.WuW.SyedF.OrrK. S.et al (2019). Hypusine biosynthesis in β cells links polyamine metabolism to facultative cellular proliferation to maintain glucose homeostasis. Sci. Signal12 (610), eaax0715. 10.1126/scisignal.aax0715

  • 34

    LiJ.Van VrankenJ. G.Pontano VaitesL.SchweppeD. K.HuttlinE. L.EtienneC.et al (2020). TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples. Nat. Methods17 (4), 399404. 10.1038/s41592-020-0781-4

  • 35

    LieselotL. G.CarretteE. A. S.GeorgeO. (2023) Neurocircuitry of addiction - amygdala circuits.

  • 36

    MachtV.VetrenoR.ElchertN.CrewsF. (2021). Galantamine prevents and reverses neuroimmune induction and loss of adult hippocampal neurogenesis following adolescent alcohol exposure. J. Neuroinflammation18 (1), 212. 10.1186/s12974-021-02243-7

  • 37

    MaistoS. A.PollockN. K.CorneliusJ. R.LynchK. G.MartinC. S. (2003). Alcohol relapse as a function of relapse definition in a clinical sample of adolescents. Addict. Behav.28 (3), 449459. 10.1016/s0306-4603(01)00267-2

  • 38

    MarshallS. A.GeilC. R.NixonK. (2016). Prior binge ethanol exposure potentiates the microglial response in a model of alcohol-induced neurodegeneration. Brain Sci.6 (2), 16. 10.3390/brainsci6020016

  • 39

    McLellanA. T.LewisD. C.O'BrienC. P.KleberH. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA284 (13), 16891695. 10.1001/jama.284.13.1689

  • 40

  • 41

    PatrizioM.LeviG. (1994). Glutamate production by cultured microglia: differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents. Neurosci. Lett.178 (2), 184189. 10.1016/0304-3940(94)90755-2

  • 42

    Peck JusticeS. A.McCrackenN. A.VictorinoJ. F.QiG. D.WijeratneA. B.MosleyA. L. (2021). Boosting detection of low-abundance proteins in thermal proteome profiling experiments by addition of an isobaric trigger channel to TMT multiplexes. Anal. Chem.93 (18), 70007010. 10.1021/acs.analchem.1c00012

  • 43

    PlubellD. L.WilmarthP. A.ZhaoY.FentonA. M.MinnierJ.ReddyA. P.et al (2017). Extended multiplexing of Tandem mass tags (TMT) labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue. Mol. Cell Proteomics16 (5), 873890. 10.1074/mcp.M116.065524

  • 44

    QinL.CrewsF. T. (2012). NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J. Neuroinflammation9, 5. 10.1186/1742-2094-9-5

  • 45

    QiuB.LuczakS. E.WallT. L.KirchhoffA. M.XuY.EngM. Y.et al (2016). The FKBP5 gene affects alcohol drinking in knockout mice and is implicated in alcohol drinking in humans. Int. J. Mol. Sci.17 (8), 1271. 10.3390/ijms17081271

  • 46

    Rivera-IrizarryJ. K.ZallarL. J.LevineO. B.SkellyM. J.BoyceJ. E.BarneyT.et al (2023). Sex differences in binge alcohol drinking and the behavioral consequences of protracted abstinence in C57BL/6J mice. Biol. Sex. Differ.14 (1), 83. 10.1186/s13293-023-00565-0

  • 47

    SamhsaC. f.B. H. S. a.Q. (2021). National Survey on Drug Use and Health. Table 5.6A—alcohol use disorder in past year: among people aged 12 or older; by age group and demographic characteristics. Available at: https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-use-disorder-aud-united-states-age-groups-and-demographic-characteristics.

  • 48

    ShenY.LindemeyerA. K.SpigelmanI.SieghartW.OlsenR. W.LiangJ. (2011). Plasticity of GABAA receptors after ethanol pre-exposure in cultured hippocampal neurons. Mol. Pharmacol.79 (3), 432442. 10.1124/mol.110.068650

  • 49

    SiemsenB. M.LandinJ. DMcFaddinJ. A.HookerK. N.ChandlerL. J.ScofieldM. D. (2021). Chronic intermittent ethanol exposure differentially alters microglial morphology in the prelimbic cortex and nucleus accumbens core. J. Neurosci. Res.99 (8), 19221939. 10.1002/jnr.24683

  • 50

    SpinolaS.De VitaM. J.GilmourC. E.MaistoS. A. (2022). Effects of acute alcohol administration on working memory: a systematic review and meta-analysis. Psychopharmacology239 (3), 695708. 10.1007/s00213-022-06060-5

  • 51

    Substance Abuse and Mental Health Services Administration (2016). “Facing addiction in America: the surgeon general's report on alcohol, drugs, and health,” in The neurobiology of substance use, misuse, and addiction: national Institute on alcohol Abuse and alcoholism (Washington, DC, USA: US Department of Health and Human Services).

  • 52

    SulzerD. (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron69 (4), 628649. 10.1016/j.neuron.2011.02.010

  • 53

    SupekF.BošnjakM.ŠkuncaN.ŠmucT. (2011). REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One6 (7), e21800. 10.1371/journal.pone.0021800

  • 54

    SwartzwelderH. S.HealeyK. L.LiuW.DubesterK.MillerK. M.CrewsF. T. (2019). Changes in neuroimmune and neuronal death markers after adolescent alcohol exposure in rats are reversed by donepezil. Sci. Rep.9 (1), 12110. 10.1038/s41598-019-47039-1

  • 55

    SzymanskaM.BudziszewskaB.Jaworska-FeilL.Basta-KaimA.KuberaM.LeśkiewiczM.et al (2009). The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology34 (6), 822832. 10.1016/j.psyneuen.2008.12.012

  • 56

    TatenoM.SaitoT. (2008). Biological studies on alcohol-induced neuronal damage. Psychiatry Investig.5 (1), 2127. 10.4306/pi.2008.5.1.21

  • 57

    ToescaA.GiannettiS.GranatoA. (2003). Overexpression of the p75 neurotrophin receptor in the sensori-motor cortex of rats exposed to ethanol during early postnatal life. Neurosci. Lett.342 (1-2), 8992. 10.1016/s0304-3940(03)00258-1

  • 58

    TomasiM. L.RamaniK.RyooM.CossuC.FlorisA.MurrayB. J.et al (2018). SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease. FASEB J.32 (6), 32783288. 10.1096/fj.201701124R

  • 59

    TomasiM. L.TomasiI.RamaniK.PascaleR. M.XuJ.GiordanoP.et al (2012). S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology56 (3), 982993. 10.1002/hep.25701

  • 60

    TopiwalaA.AllanC. L.ValkanovaV.ZsoldosE.FilippiniN.SextonC.et al (2017). Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ357, j2353. 10.1136/bmj.j2353

  • 61

    ValentinV. V.DickinsonA.O'DohertyJ. P. (2007). Determining the neural substrates of goal-directed learning in the human brain. J. Neurosci.27 (15), 40194026. 10.1523/JNEUROSCI.0564-07.2007

  • 62

    WangS.NiH. M.DorkoK.KumerS. C.SchmittT. M.NawabiA.et al (2016). Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget7 (14), 1768117698. 10.18632/oncotarget.6893

  • 63

    WilcoxC. E.DekonenkoC. J.MayerA. R.BogenschutzM. P.TurnerJ. A. (2014). Cognitive control in alcohol use disorder: deficits and clinical relevance. Rev. Neurosci.25 (1), 124. 10.1515/revneuro-2013-0054

  • 64

    WilluhnI.BurgenoL. M.EverittB. J.PhillipsP. E. M. (2012). Hierarchical recruitment of phasic dopamine signaling in the striatum during the progression of cocaine use. Proc. Natl. Acad. Sci. U. S. A.109 (50), 2070320708. 10.1073/pnas.1213460109

  • 65

    ZouJ. Y.CrewsF. T. (2005). TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res.1034 (1-2), 1124. 10.1016/j.brainres.2004.11.014

Summary

Keywords

alcohol, alcohol abstinence, chronic alcohol consumption, striatum, inflammation, proteomics

Citation

Duffus BM, Haggerty DL, Doud EH, Mosley AL, Yamamoto BK and Atwood BK (2024) The impact of abstinence from chronic alcohol consumption on the mouse striatal proteome: sex and subregion-specific differences. Front. Pharmacol. 15:1405446. doi: 10.3389/fphar.2024.1405446

Received

22 March 2024

Accepted

13 May 2024

Published

03 June 2024

Volume

15 - 2024

Edited by

Regina A. Mangieri, The University of Texas at Austin, United States

Reviewed by

David F. Werner, Binghamton University, United States

Victoria Macht, University of North Carolina at Chapel Hill, United States

John J. Woodward, Medical University of South Carolina, United States

Luis Alberto Natividad, The University of Texas at Austin, United States

Updates

Copyright

*Correspondence: Brady K. Atwood,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics